A new brand in clinical trial logistics - Pharmaceutical Technology

Founded in 2004, the SMO Group has a strong heritage in clinical trial logistics. Now, it is entering the next phase of its brand journey, as Oximio.

Free Whitepaper

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.

By downloading this case study, you acknowledge that GlobalData may share your information with Oximio and that your personal data will be used as described in their Privacy Policy Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Free Whitepaper

Unlocking the clinical trial potential of Africa

By Oximio